Sarah Boyce serves as Executive at IONIS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Sarah Boyce has executed 82 insider transactions totaling $30.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 18, 2025 involved gifting 29,159 shares valued at $0.
Sarah Boyce currently holds 291,970 shares of IONIS PHARMACEUTICALS INC (IONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Boyce has been a net seller of IONS stock. They have purchased $101.3K and sold $30.0M worth of shares.
Sarah Boyce's most recent insider trade was on Dec 18, 2025, when they sold 29,159 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $71.87 |
| Discretionary |
| Dec 17, 2025 | RNA | $0 | Award | 31,000 | $N/A | Discretionary |
| Sep 5, 2025 | RNA | $62.0K | Option Exercise | 50,000 | $1.24 | Discretionary |
| Sep 5, 2025 | RNA | $2.5M | Sale | 50,000 | $49.95 | Discretionary |
| Aug 28, 2025 | RNA | $1.2M | Sale | 25,000 | $49.39 | Discretionary |
| Aug 28, 2025 | RNA | $31.0K | Option Exercise | 25,000 | $1.24 | Discretionary |
| Sep 23, 2024 | RNA | $1.4M | Sale | 32,880 | $44.00 | Planned |
| Sep 19, 2024 | RNA | $0 | Award | 62,500 | $N/A | Planned |
| Sep 19, 2024 | RNA | $0 | Award | 62,500 | $N/A | Planned |
| Aug 6, 2024 | RNA | $1.2M | Sale | 28,000 | $43.35 | Planned |
| Aug 6, 2024 | RNA | $34.7K | Option Exercise | 28,000 | $1.24 | Planned |
| Jul 9, 2024 | RNA | $34.7K | Option Exercise | 28,000 | $1.24 | Planned |
| Jul 9, 2024 | RNA | $1.1M | Sale | 28,000 | $39.93 | Planned |
| Jun 18, 2024 | RNA | $1.3M | Sale | 32,074 | $39.13 | Planned |
| Jun 18, 2024 | OABI | $0 | Option Exercise | 20,000 | $N/A | Discretionary |
| Jun 17, 2024 | RNA | $0 | Award | 62,500 | $N/A | Planned |
| Jun 17, 2024 | RNA | $0 | Award | 62,500 | $N/A | Planned |
| Jun 14, 2024 | RNA | $1.4M | Sale | 35,767 | $40.08 | Planned |
| Jun 14, 2024 | RNA | $44.4K | Option Exercise | 35,767 | $1.24 | Planned |
| Jun 13, 2024 | RNA | $203.6K | Option Exercise | 164,233 | $1.24 | Planned |
| Jun 13, 2024 | RNA | $6.6M | Sale | 164,233 | $40.08 | Planned |
| Jun 12, 2024 | RNA | $3.6M | Sale | 100,000 | $35.73 | Planned |
| Jun 12, 2024 | RNA | $124.0K | Option Exercise | 100,000 | $1.24 | Planned |
| Jun 4, 2024 | RNA | $34.7K | Option Exercise | 28,000 | $1.24 | Planned |
| Jun 4, 2024 | RNA | $767.8K | Sale | 28,000 | $27.42 | Planned |
| May 7, 2024 | RNA | $715.1K | Sale | 28,000 | $25.54 | Planned |
| May 7, 2024 | RNA | $34.7K | Option Exercise | 28,000 | $1.24 | Planned |
| Apr 2, 2024 | RNA | $735.0K | Sale | 28,000 | $26.25 | Planned |
| Apr 2, 2024 | RNA | $34.7K | Option Exercise | 28,000 | $1.24 | Planned |